Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 34.99%-182.16K | 535.37%37.12K | 83.76%-20.6K | -125.21%-144.88K | 33.22%-53.8K | -39.17%-280.22K | 84.85%-8.53K | -40.02%-126.79K | -50.37%-64.33K | -587.31%-80.57K |
| Net income from continuing operations | -4.58%-203.17K | -1,146.66%-67.94K | 59.82%-41.99K | 22.98%-42.51K | -23.49%-50.73K | 74.06%-194.27K | 102.60%6.49K | -43.43%-104.49K | 86.30%-55.2K | -72.56%-41.08K |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Change In working capital | 124.44%21K | 799.60%105.06K | 195.92%21.39K | -1,020.56%-102.37K | 92.22%-3.07K | -202.78%-85.94K | -114.14%-15.02K | -26.00%-22.3K | 46.20%-9.14K | -426.80%-39.49K |
| -Change in receivables | 213.76%9.69K | -102.83%-814 | 341.85%25.79K | 28.46%-6.35K | -44.44%-8.94K | 142.34%3.09K | 723.76%28.81K | -48.72%-10.66K | -393.00%-8.87K | -239.44%-6.19K |
| -Change in prepaid assets | --0 | 952.11%78.91K | --0 | -19,827.00%-78.91K | --0 | 200.00%1.03K | 1,090.48%7.5K | -1,290.48%-7.5K | 117.47%400 | --630 |
| -Change in payables and accrued expense | 112.56%11.32K | 152.54%26.97K | -6.16%-4.39K | -2,466.87%-17.12K | 117.29%5.87K | -197.96%-90.06K | -150.28%-51.32K | 62.91%-4.14K | 94.83%-667 | -343.99%-33.93K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 34.99%-182.16K | 535.37%37.12K | 83.76%-20.6K | -125.21%-144.88K | 33.22%-53.8K | -39.17%-280.22K | 84.85%-8.53K | -40.02%-126.79K | -50.37%-64.33K | -587.31%-80.57K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 2,228.35%700.61K | -139.71%-78.91K | 762.92K | 19.6K | -3K | 95.69%-32.92K | -196.82%-32.92K | 0 | 0 | 0 |
| Net PPE purchase and sale | ---3.4K | --0 | --0 | ---400 | ---3K | --0 | --0 | --0 | --0 | --0 |
| Net investment purchase and sale | 2,238.68%704.01K | -139.71%-78.91K | --762.92K | ---- | ---- | 95.61%-32.92K | ---32.92K | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 2,228.35%700.61K | -139.71%-78.91K | --762.92K | --19.6K | ---3K | 95.69%-32.92K | -196.82%-32.92K | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 314.55K | 0 | 0 | 0 | ||||||
| Net common stock issuance | --325K | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | ---10.46K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --314.55K | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -61.30%197.73K | 216.91%757.96K | -95.73%15.64K | -67.25%140.93K | -61.30%197.73K | 1,046.82%510.86K | -55.73%239.17K | 23.31%365.96K | 1,613.71%430.3K | 1,046.82%510.86K |
| Current changes in cash | 366.02%832.99K | 758.13%272.76K | 685.47%742.32K | -94.75%-125.28K | 29.50%-56.8K | -167.15%-313.13K | -41.14%-41.44K | -152.08%-126.79K | -123.68%-64.33K | -314.50%-80.57K |
| End cash Position | 421.28%1.03M | 421.28%1.03M | 216.91%757.96K | -95.73%15.64K | -67.25%140.93K | -61.30%197.73K | -61.30%197.73K | -55.73%239.17K | 23.31%365.96K | 1,613.71%430.3K |
| Free cash from | 33.78%-185.56K | 535.37%37.12K | 83.76%-20.6K | -125.83%-145.28K | 29.50%-56.8K | -30.29%-280.22K | 61.75%-8.53K | -40.02%-126.79K | 22.29%-64.33K | -314.50%-80.57K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.